drugset / Trial / NCT03473249

Effectiveness of Contrast-Enhanced Ultrasound

NCT03473249

Phase 4 Active not recruiting 120 enrolled Children's Hospital of Philadelphia
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The purpose of the study is to generate pilot data describing test characteristics of contrast enhanced ultrasound in young children with concern for abdominal trauma. The primary objective in this study is to determine the sensitivity and specificity of contrast-enhanced ultrasound (CEUS) compared to abdominal Computed Tomography (CT) in the detection of abdominal solid organ injury in young children \< 8 years of age with concern for blunt abdominal trauma.

Timeline

Start
2018-05-09
Primary completion
2026-12
Completion
2026-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lumason Diagnostic / imaging agent 25 mg Intravenous

Indications

No indication recorded.